Progress in the Treatment of Locally Advanced Clinically Resectable Rectal Cancer-Reference-Cited by-同舟云学术

Progress in the Treatment of Locally Advanced Clinically Resectable Rectal Cancer

Published:2011-12 Issue:4 Volume:10 Page:227-237
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Minsky Bruce D.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference125 articles.

1. Effective surgical adjuvant therapy for high-risk rectal carcinoma;Krook;N Engl J Med,1991

2. Capecitabine as adjuvant treatment for stage III colon cancer;Twelves;N Engl J Med,2005

3. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum NSABP R-04;Roh;J Clin Oncol,2011

4. Capecitabine (Cape) versus 5-fluorouracil (5-FU) based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): long-term results of a randomized, phase III trial;Hofheinz;J Clin Oncol,2011

5. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;N Engl J Med,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States;Cancer Epidemiology Biomarkers & Prevention;2020-09-30

2. Sequential Boost in Neoadjuvant Irradiation for T3N0-1 Rectal Cancer: Long-Term Results from a Single-Center Experience;Tumori Journal;2016-03-16

3. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy;Oncotarget;2015-07-22

4. Surveillance, Epidemiology, and End Results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer;Cancer Epidemiology;2014-02

5. EURECCA consensus conference highlights about rectal cancer clinical management: The radiation oncologist’s expert review;Radiotherapy and Oncology;2014-01